Compare Amphastar Pharmaceuticals Inc (AMPH) vs First Trust NASDAQ Clean Edge Green Energy Idx Fd (QCLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $52.72. The key difference: First Trust NASDAQ Clean Edge Green Energy Idx Fd is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | QCLN | |
|---|---|---|
Market Cap | $863.95M | — |
Sector | Health | Sector/Thematic |
52-Week High | $30.81 | $68.47 |
52-Week Low | $16.87 | $36.11 |
Enterprise Value | $1.26B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
QCLN, a clean energy ETF, trades at $52.82, up 2.46% today, with a bullish technical signal from moving averages and neutral oscillators. Support lies at $51 and resistance at $53. The fund benefits from growing global investment in renewables and rising electricity demand, though policy uncertainties and supply chain costs pose challenges.
The outlook for QCLN is positive due to structural shifts toward clean energy, but investors face risks from regulatory delays and geopolitical tensions affecting solar and wind projects. Wall Street sentiment is cautiously optimistic, with clean energy ETFs gaining attention for long-term growth potential amid volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About First Trust NASDAQ Clean Edge Green Energy Idx Fd
QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →
